Prudential Financial’s Integra LifeSciences IART Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.31M Buy
73,001
+900
+1% +$12.6K ﹤0.01% 1564
2026
Q1
$679K Buy
72,101
+7,760
+12% +$85.2K ﹤0.01% 1751
2025
Q4
$799K Sell
64,341
-4,616
-7% -$61.4K ﹤0.01% 1684
2025
Q3
$988K Hold
68,957
﹤0.01% 1658
2025
Q2
$846K Sell
68,957
-7,204
-9% -$105K ﹤0.01% 1730
2025
Q1
$1.67M Sell
76,161
-11,960
-14% -$281K ﹤0.01% 1359
2024
Q4
$2M Sell
88,121
-120,100
-58% -$2.62M ﹤0.01% 1299
2024
Q3
$3.78M Buy
208,221
+132,502
+175% +$3.07M 0.01% 1117
2024
Q2
$2.21M Buy
75,719
+69,906
+1,203% +$2.07M ﹤0.01% 1373
2024
Q1
$206K Sell
5,813
-451
-7% -$18K ﹤0.01% 2463
2023
Q4
$273K Sell
6,264
-10,077
-62% -$397K ﹤0.01% 2353
2023
Q3
$624K Sell
16,341
-29,375
-64% -$1.24M ﹤0.01% 1979
2023
Q2
$1.88M Sell
45,716
-26,238
-36% -$1.26M ﹤0.01% 1441
2023
Q1
$4.13M Sell
71,954
-7,518
-9% -$424K 0.01% 948
2022
Q4
$4.46M Sell
79,472
-62,575
-44% -$3.18M 0.01% 917
2022
Q3
$6.18M Buy
142,047
+49,137
+53% +$2.52M 0.01% 812
2022
Q2
$5.19M Buy
92,910
+58,204
+168% +$3.5M 0.01% 878
2022
Q1
$2.23M Sell
34,706
-5,331
-13% -$351K ﹤0.01% 1442
2021
Q4
$2.86M Buy
40,037
+2,544
+7% +$172K ﹤0.01% 1338
2021
Q3
$2.61M Buy
37,493
+3,975
+12% +$281K ﹤0.01% 1320
2021
Q2
$2.29M Sell
33,518
-8,090
-19% -$572K ﹤0.01% 1412
2021
Q1
$2.88M Sell
41,608
-16,944
-29% -$1.15M ﹤0.01% 1277
2020
Q4
$3.8M Buy
58,552
+40,574
+226% +$2.18M 0.01% 1123
2020
Q3
$850K Buy
17,978
+2,025
+13% +$96.3K ﹤0.01% 1717
2020
Q2
$749K Sell
15,953
-180,778
-92% -$8.89M ﹤0.01% 1759
2020
Q1
$8.79M Sell
196,731
-110,204
-36% -$5.78M 0.02% 684
2019
Q4
$17.9M Buy
306,935
+102,101
+50% +$6.08M 0.03% 627
2019
Q3
$12.3M Buy
204,834
+46,593
+29% +$2.78M 0.02% 723
2019
Q2
$8.84M Buy
158,241
+116,635
+280% +$6.01M 0.01% 892
2019
Q1
$2.32M Buy
41,606
+165
+0.4% +$8.4K ﹤0.01% 1533
2018
Q4
$1.87M Sell
41,441
-2,949
-7% -$162K ﹤0.01% 1544
2018
Q3
$2.92M Buy
44,390
+51
+0.1% +$3.17K ﹤0.01% 1444
2018
Q2
$2.86M Sell
44,339
-64,627
-59% -$4M ﹤0.01% 1470
2018
Q1
$6.03M Buy
108,966
+1,960
+2% +$103K 0.01% 1094
2017
Q4
$5.12M Buy
107,006
+1,170
+1% +$57.3K 0.01% 1147
2017
Q3
$5.34M Buy
105,836
+3,340
+3% +$172K 0.01% 1118
2017
Q2
$5.59M Sell
102,496
-460
-0.4% -$22K 0.01% 1094
2017
Q1
$4.34M Sell
102,956
-75,240
-42% -$3.21M 0.01% 1183
2016
Q4
$7.64M Buy
178,196
+71,160
+66% +$2.89M 0.01% 944
2016
Q3
$4.42M Sell
107,036
-35,000
-25% -$1.47M 0.01% 1121
2016
Q2
$5.67M Sell
142,036
-960
-0.7% -$34.5K 0.01% 1043
2016
Q1
$4.82M Buy
142,996
+8,200
+6% +$255K 0.01% 1117
2015
Q4
$4.57M Buy
134,796
+3,000
+2% +$93.8K 0.01% 1101
2015
Q3
$3.92M Sell
131,796
-9,776
-7% -$306K 0.01% 1146
2015
Q2
$3.9M Buy
141,572
+2,446
+2% +$65.2K 0.01% 1222
2015
Q1
$3.51M Buy
139,126
+1,223
+0.9% +$28.9K 0.01% 1312
2014
Q4
$3.06M Buy
137,903
+2,202
+2% +$44.6K 0.01% 1241
2014
Q3
$2.75M Sell
135,701
-1,849
-1% -$36.8K 0.01% 1252
2014
Q2
$2.65M Buy
137,550
+4,760
+4% +$88.7K ﹤0.01% 1366
2014
Q1
$2.5M Buy
132,790
+2,202
+2% +$42.5K ﹤0.01% 1343
2013
Q4
$2.55M Buy
130,588
+15,780
+14% +$289K 0.01% 1319
2013
Q3
$1.89M Sell
114,808
-69,071
-38% -$1.11M ﹤0.01% 1446
2013
Q2
$2.75M Buy
+183,879
New +$2.69M 0.01% 1193

Other funds holding IART

Prudential Financial's IART Position: Q2 2026 in Review

Prudential Financial increased its Integra LifeSciences (IART) stake by 1.2% in Q2 2026, buying an estimated $12.6K and bringing the position to 73,001 shares worth $1.31M. The position accounts for ﹤0.01% of the portfolio, ranked #1564.

Prudential Financial first reported a position in IART in Q2 2013 and has held it in 53 quarters since. The position peaked at $17.9M in Q4 2019. 213 funds tracked by Wall St. Rank hold IART as of Q2 2026.

  • Prudential Financial held 73,001 shares of Integra LifeSciences worth $1.31M as of Q2 2026.
  • Prudential Financial bought 900 Integra LifeSciences shares in Q2 2026, an estimated $12.6K.
  • Integra LifeSciences made up ﹤0.01% of Prudential Financial's portfolio in Q2 2026, its #1564 holding.
  • Prudential Financial first reported a position in Integra LifeSciences in Q2 2013 and has held it in 53 quarters since.
  • Prudential Financial's Integra LifeSciences position peaked at $17.9M in Q4 2019.
  • 213 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2026.

Based on Prudential Financial's 13F filing for Q2 2026, filed 12 Aug 2026.